PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Latest Episodes:

Thomas Grader-Beck, MD - Beneath the Surface of Sjögren’s Disease: Understanding Systemic Impact and B-Cell–Mediated Pathways Dec 29, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TWU865. CME credit will be available until December 16, 2026.

Beneath the Surface of Sjögren’s Disease: Understanding Systemic Impact and B-Cell–Mediated Pathways

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.

Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Disclosure information is available at the beginning of the video presentation.

Geoffrey Ku, MD - Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians Dec 29, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KFF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until December 21, 2026.

Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians

In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.

Disclosure information is available at the beginning of the video presentation.

Manmeet S. Ahluwalia, MD, MBA, FASCO - Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Evidence on Molecularly Targeted Therapies in IDH-Mutant Disease Dec 29, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TBU865. CME/MOC/AAPA credit will be available until December 20, 2026.

Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Evidence on Molecularly Targeted Therapies in IDH-Mutant Disease

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and American Brain Tumor Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an educational grant from Servier Pharmaceuticals LLC.

Disclosure information is available at the beginning of the video presentation.

Gil Rabinovici, MD - Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025 Dec 29, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/KPN865. CME/MOC/NCPD/AAPA credit will be available until December 23, 2026.

Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025

Support
This activity is supported by an educational grant from Lilly.

Disclosure information is available at the beginning of the video presentation.

Milind Desai, MD, MBA, Anjali Tiku Owens, MD - Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors Dec 26, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.

Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors

Support
This activity is supported through an educational grant from Bristol Myers Squibb.

Disclosure information is available at the beginning of the video presentation.

Scott A. Kaiser, MD / Lisa C. McGuire, PhD, FGSA - Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia Dec 26, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.

Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an educational grant from Lilly.

Disclosure information is available at the beginning of the video presentation.

Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On! Dec 18, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZYK865. CME/MOC/CC/AAPA credit will be available until December 15, 2026.

Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!

Support
This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.

Disclosure information is available at the beginning of the video presentation.

Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease Dec 18, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete EBAH/CME information, and to apply for credit, please visit us at PeerView.com/BNE865. EBAH/CME credit will be available until November 25, 2026.

The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease

Support
This activity is supported by an educational grant from Servier.

Disclosure information is available at the beginning of the video presentation.

Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments Dec 12, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/MNA865. CME/MOC/CC/AAPA credit will be available until November 18, 2026.

The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments

Support
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Disclosure information is available at the beginning of the video presentation.

Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease Dec 12, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.

Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease

Support
This activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.

Disclosure information is available at the beginning of the video presentation.